title: Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers.
authors.affiliation: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, Taiwan.
authors.forename: T-Y
authors.initials: TY
authors.lastname: Wei
authors.affiliation: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, Taiwan.
authors.forename: C-C
authors.initials: CC
authors.lastname: Wang
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D004279:DNA, Viral; D006509:Hepatitis B; D006514:Hepatitis B Surface Antigens; D006515:Hepatitis B virus; D019694:Hepatitis B, Chronic; D006801:Humans; D008113:Liver Neoplasms
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens